BAC
Bank of America Corporation
BAC has the edge over ITUB overall, supported by lower modeled downside and stronger fundamentals.
ITUB
Itaú Unibanco Holding S.A.
ITUB trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ITUB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
ITUB's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like ITUB.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
ITUB PE Valuation
ITUB has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over ITUB on the outlook, with more favorable earnings and revenue expectations.
ITUB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect ITUB's profitability to improve, with its earnings and revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over ITUB on earnings, with more consistent year-over-year improvement.
ITUB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.73 | +1.4% |
| Q1 2026 | $0.71 | -1.4% |
| Q4 2025 | $0.71 | 0% |
| Q3 2025 | $0.74 | +8.8% |
| Q2 2025 | $0.72 | +7.5% |
| Q1 2025 | $0.72 | +11% |
| Q4 2024 | $0.71 | +18% |
| Q3 2024 | $0.68 | +17% |
ITUB earned $0.73 per share over the past year, up 1.4% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over ITUB on profitability, with a higher operating margin.
ITUB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $17.8B | -2.6% |
| Q1 2026 | $17.3B | +1.5% |
| Q4 2025 | $16.4B | +12% |
| Q3 2025 | $17.2B | +28% |
| Q2 2025 | $18.2B | +21% |
| Q1 2025 | $17B | +22% |
| Q4 2024 | $14.7B | +10% |
| Q3 2024 | $13.5B | -6.1% |
ITUB's revenue is growing: $17.8B last quarter, down 2.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +4.8 points |
| Q1 2026 | 13% | -0.4 points |
| Q4 2025 | 15% | -0.7 points |
| Q3 2025 | 14% | +1 points |
| Q2 2025 | 9.5% | -5.1 points |
| Q1 2025 | 14% | -2.1 points |
| Q4 2024 | 16% | +2.4 points |
| Q3 2024 | 13% | +0.2 points |
ITUB's operating margin was 14% last quarter, up 4.8 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
ITUB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $12.8B | +489% |
| Q1 2026 | -$1.1B | +$1.4B |
| Q4 2025 | $8.1B | +762% |
| Q3 2025 | $13.3B | +$20B |
| Q2 2025 | $2.2B | +$2.6B |
| Q1 2025 | -$2.4B | -129% |
| Q4 2024 | $935.4M | +$4.2B |
| Q3 2024 | -$6.8B | -$6.2B |
ITUB has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over ITUB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ITUB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +27.7M shares |
| 1 year | +2.5% | +273M shares |
| 3 years | +13% | +1.3B shares |
| 5 years | +13% | +1.3B shares |
| Available history | +14% | +1.3B shares |
ITUB has 11.1B diluted shares, up 2.5% from a year ago, despite $1.2B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $300.6M |
| Q1 2026 | $309.2M |
| Q4 2025 | $214M |
| Q3 2025 | $342.1M |
| Q2 2025 | — |
| Q1 2025 | $14.9M |
| Q4 2024 | $18.1M |
| Q3 2024 | — |
ITUB spent $1.2B buying back its own shares over the past year, more than ten times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC has the edge over ITUB on leverage, with a lower net debt burden relative to earnings.
ITUB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 12.0x | High |
| Q1 2026 | 14.1x | High |
| Q4 2025 | 12.9x | High |
| Q3 2025 | 12.8x | High |
| Q2 2025 | 13.1x | High |
| Q1 2025 | 12.0x | High |
| Q4 2024 | 12.0x | High |
| Q3 2024 | 13.0x | High |
ITUB's net debt is about 12 years of its operating earnings (EBITDA), down from 13 years a year ago. Net leverage isn't a meaningful measure for financial services companies like ITUB.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ITUB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.6 | Neutral |
| Stochastic | 9.4 | Oversold |
ITUB's weekly RSI is 44 (neutral) and its Stochastic is 9 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
ITUB PE vs Financial Services Sector
| Metric | ITUB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
ITUB has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
ITUB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.48 | 13% below |
| 20 week MA | $8.23 | 10% below |
| 50 week MA | $8.17 | 9.8% below |
| 100 week MA | $7.20 | 2.4% above |
| 200 week MA | $6.29 | 17% above |
ITUB has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
ITUB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.82 | $4.64 | -32% |
| 2021 | $4.64 | $3.40 | -27% |
| 2022 | $3.40 | $4.43 | +30% |
| 2023 | $4.43 | $6.32 | +43% |
| 2024 | $6.32 | $4.53 | -28% |
| 2025 | $4.53 | $7.10 | +57% |
| 2026 YTD | $7.10 | $7.37 | +3.8% |
ITUB has the edge over BAC on returns for 2026, with the stronger performance.